ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM)Sylvia C. Kurz, Lakshmi Nayak, Isabel Arrillaga‐Romany et al.|Neuro-Oncology|2019Cited by 3
Prospective Evaluation of Bleeding Incidence in Fibrinogen Deficiency (PRO-RBDD Study)Roberta Palla, Flora Peyvandi, Marzia Menegatti et al.|Blood|2016Cited by 0